PH22141A - N-aralkyl piperidinemethanol derivatives and method of use thereof - Google Patents

N-aralkyl piperidinemethanol derivatives and method of use thereof

Info

Publication number
PH22141A
PH22141A PH33962A PH33962A PH22141A PH 22141 A PH22141 A PH 22141A PH 33962 A PH33962 A PH 33962A PH 33962 A PH33962 A PH 33962A PH 22141 A PH22141 A PH 22141A
Authority
PH
Philippines
Prior art keywords
aralkyl
derivatives
piperidinemethanol derivatives
aralkyl piperidinemethanol
piperidinemethanol
Prior art date
Application number
PH33962A
Other languages
English (en)
Inventor
Albert A Carr
Norbert L Wiech
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of PH22141A publication Critical patent/PH22141A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH33962A 1985-07-02 1986-06-27 N-aralkyl piperidinemethanol derivatives and method of use thereof PH22141A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75141985A 1985-07-02 1985-07-02

Publications (1)

Publication Number Publication Date
PH22141A true PH22141A (en) 1988-06-01

Family

ID=25021900

Family Applications (1)

Application Number Title Priority Date Filing Date
PH33962A PH22141A (en) 1985-07-02 1986-06-27 N-aralkyl piperidinemethanol derivatives and method of use thereof

Country Status (21)

Country Link
EP (1) EP0208235B1 (no)
JP (1) JPH0655720B2 (no)
KR (1) KR900001184B1 (no)
CN (1) CN1023895C (no)
AR (2) AR241904A1 (no)
AT (1) ATE49403T1 (no)
AU (1) AU590582B2 (no)
CA (1) CA1280421C (no)
DE (1) DE3668167D1 (no)
DK (1) DK174153B1 (no)
ES (1) ES2000299A6 (no)
FI (1) FI84474C (no)
GR (1) GR861699B (no)
HU (1) HU196058B (no)
IE (1) IE58460B1 (no)
IL (1) IL79266A (no)
NO (1) NO167384C (no)
NZ (1) NZ216689A (no)
PH (1) PH22141A (no)
PT (1) PT82890B (no)
ZA (1) ZA864772B (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910006138B1 (ko) * 1986-09-30 1991-08-16 에자이 가부시끼가이샤 환상아민 유도체
ZA888572B (en) * 1987-11-23 1989-08-30 Merrell Dow Pharma Treatment of fibromyalgia
JPH02138214A (ja) * 1987-12-10 1990-05-28 Merrell Dow Pharmaceut Inc 不安を治療する方法
US5093341A (en) * 1987-12-17 1992-03-03 Merrell Dow Pharmaceuticals Inc. N-aralkyl piperidine derivatives useful as antithrombolytic agents
DE3888340T2 (de) * 1988-01-21 1994-06-30 Merrell Dow Pharma Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
ZA891901B (en) * 1988-03-17 1989-11-29 Merrell Dow Pharma Method for the treatment of the extrapyramidal side effects associated with neuroleptic therapy
JP2969359B2 (ja) * 1989-01-13 1999-11-02 武田薬品工業株式会社 環状アミン化合物
US5032598A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents
ZA9010081B (en) * 1989-12-20 1991-10-30 Merrell Dow Pharma Method for the treatment of glaucoma
JP2758050B2 (ja) * 1989-12-27 1998-05-25 株式会社トクヤマ 土質安定用薬液およびその注入工法
US6004980A (en) * 1990-06-01 1999-12-21 Merrell Pharmaceuticals, Inc. (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
WO1991018602A1 (en) * 1990-06-01 1991-12-12 Merrell Dow Pharmaceuticals Inc. (+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL
JPH07111050B2 (ja) * 1990-12-12 1995-11-29 株式会社親和テクノ セメントグラウトを用いた地盤注入工法
FR2672286B1 (fr) * 1991-01-31 1994-11-18 Synthelabo Derives de 1-(4-chlorophenyl)-2-[4-(phenylmethyl)piperidin-1-yl]ethanol, leur preparation et leur application en therapeutique.
ZA929008B (en) * 1991-12-13 1993-05-21 Bristol Myers Squibb Co Piperazinyl- and piperidinyl-cyclohexanols.
WO1994000432A1 (en) * 1992-06-30 1994-01-06 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Anorectic epinephrine derivatives
FR2696741B1 (fr) * 1992-10-12 1994-11-25 Synthelabo Dérivés de 1-(4-chlorophényl)-2-[4-[(4-fluorophényl)méthyl]piperidin-1-yl] éthanol, leur préparation et leur application en thérapeutique.
CA2108245A1 (en) * 1992-11-04 1994-05-05 Gary J. Grover Method for treating myocardial ischemia employing serotonin receptor antagonists
EP0661266A1 (en) * 1993-12-27 1995-07-05 Toa Eiyo Ltd. Substituted cyclic amine compounds as 5HT2 antagonists
AU1301497A (en) * 1995-12-20 1997-07-14 Reinhard Laven Novel 1-phenylalkyl/alkylene-4-(.alpha.-hydroxydiphenylmethyl)-pip eridine derivatives and their use as serotonin antagonists
US6028083A (en) * 1997-07-25 2000-02-22 Hoechst Marion Roussel, Inc. Esters of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
US6713627B2 (en) 1998-03-13 2004-03-30 Aventis Pharmaceuticals Inc. Processes for the preparation of (R)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
TWI249526B (en) * 1998-03-13 2006-02-21 Aventis Pharma Inc Novel processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
SE9801516D0 (sv) * 1998-04-30 1998-04-30 Maria Carlsson M100907/4-Piperidinemethanol derivatives for autism
DE19934432A1 (de) 1999-07-22 2001-02-01 Merck Patent Gmbh Indolderivate
DE19939756A1 (de) * 1999-08-21 2001-02-22 Merck Patent Gmbh Piperidinalkohole
US7345096B2 (en) 2002-10-15 2008-03-18 Wyeth Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
US7491723B2 (en) 2003-10-14 2009-02-17 Wyeth Alkanol and cycloalkanol-amine derivatives and methods of their use
US7550485B2 (en) 2003-10-14 2009-06-23 Wyeth Substituted N-heterocycle derivatives and methods of their use
US7365076B2 (en) 2003-10-14 2008-04-29 Wyeth Substituted aryl cycloalkanol derivatives and methods of their use
US7402698B2 (en) 2003-10-14 2008-07-22 Wyeth Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
US7419980B2 (en) 2003-10-14 2008-09-02 Wyeth Fused-aryl and heteroaryl derivatives and methods of their use
US7531543B2 (en) 2003-10-14 2009-05-12 Wyeth Phenylpiperazine cycloalkanol derivatives and methods of their use
US7524846B2 (en) 2003-10-14 2009-04-28 Wyeth Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
PT1691811E (pt) 2003-12-11 2014-10-30 Sunovion Pharmaceuticals Inc Combinação de um sedativo e de um modulador de neurotransmissores e métodos para melhorar a qualidade do sono e tratamento da depressão
DE102004010132A1 (de) 2004-02-27 2005-09-15 Merck Patent Gmbh Piperidinderivate
US7414052B2 (en) 2004-03-30 2008-08-19 Wyeth Phenylaminopropanol derivatives and methods of their use
US7517899B2 (en) 2004-03-30 2009-04-14 Wyeth Phenylaminopropanol derivatives and methods of their use
US20060069124A1 (en) * 2004-09-07 2006-03-30 Rao P S Use of MDL-100,907 for treatment of allergic and eosinophil mediated diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3100775A (en) * 1959-04-01 1963-08-13 Searle & Co alpha-phenyl(pyridyl or piperidyl)alkyl esters of (chloro or lower alkoxy)-benzoic acids and congeners
ZA717147B (en) * 1970-11-27 1972-07-26 Richardson Merrell Inc 4-(4-(alpha-hydroxybenzyl)piperidino)-4'-fluorobutyrophenone derivatives
SE7409245L (no) * 1973-07-19 1975-01-20 Robins Co Inc A H
FR2534580A1 (fr) * 1982-10-13 1984-04-20 Synthelabo Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent
KR910006138B1 (ko) * 1986-09-30 1991-08-16 에자이 가부시끼가이샤 환상아민 유도체

Also Published As

Publication number Publication date
FI862801A0 (fi) 1986-07-01
JPS625955A (ja) 1987-01-12
HUT41387A (en) 1987-04-28
AU5931886A (en) 1987-01-08
DK174153B1 (da) 2002-07-29
NZ216689A (en) 1989-07-27
NO862661L (no) 1987-01-05
PT82890A (en) 1986-08-01
CA1280421C (en) 1991-02-19
IE861771L (en) 1987-01-02
JPH0655720B2 (ja) 1994-07-27
FI84474B (fi) 1991-08-30
AR242184A1 (es) 1993-03-31
DE3668167D1 (de) 1990-02-15
CN1023895C (zh) 1994-03-02
NO862661D0 (no) 1986-07-01
EP0208235A1 (en) 1987-01-14
AU590582B2 (en) 1989-11-09
HU196058B (en) 1988-09-28
ES2000299A6 (es) 1988-02-16
FI84474C (fi) 1991-12-10
NO167384B (no) 1991-07-22
DK312386D0 (da) 1986-07-01
FI862801A (fi) 1987-01-03
NO167384C (no) 1991-10-30
AR241904A1 (es) 1993-01-29
DK312386A (da) 1987-01-03
IL79266A (en) 1990-04-29
CN86104408A (zh) 1987-05-20
GR861699B (en) 1986-10-31
ZA864772B (en) 1987-02-25
KR870001164A (ko) 1987-03-11
EP0208235B1 (en) 1990-01-10
ATE49403T1 (de) 1990-01-15
IE58460B1 (en) 1993-09-22
PT82890B (pt) 1988-05-27
KR900001184B1 (ko) 1990-02-27

Similar Documents

Publication Publication Date Title
PH22141A (en) N-aralkyl piperidinemethanol derivatives and method of use thereof
PL278545A1 (en) Method of obtaining novel derivatives of cyclobutylpurine and cyclobutylpyrimidine
PH23495A (en) Phenoxyalkylaminopyrimidine derivatives and the composition and method of use thereof
PH22862A (en) Novel quinoline derivatives and method of use thereof
GB2202698B (en) Microfuse and method of manufacture
GB2192248A (en) Fire-stop stack fitting and method of using same
HU896364D0 (en) Method of and apparatus
GB2215267B (en) Disposable faceshield and method of manufacture thereof
EP0235699A3 (en) Steam-shower apparatus and method of using same steam-shower apparatus and method of using same
PH21588A (en) Pleuromutilin derivatives and method of use thereof
PH22988A (en) Ascorbate 2-polyphosphate esters and method of preparing same
ZA869139B (en) Sulfomethylamide-containing polymers and method of preparing same
ZA892678B (en) Antiperspirant and method of making same
PL266143A1 (en) Weedicidal specific and the method of manufacturing of new derivatives of 2-benzoylcyclohexene-2-ane-1
PL266144A1 (en) Weedicidal specific and the method of manufacturing of new derivatives of 3-amino-2-benzoylcyclohexene-2-ane-1
PL266416A1 (en) The method of manufacture of new heterocyclic and carbocyclic condensated dihydropyridine
ZA864626B (en) Dialkylaminotetrahydrobenzothiazoles and oxazoles
GB2225038B (en) Post support and method of making same
GB8923571D0 (en) Connecting means and method of use thereof
PH24620A (en) 4-phenyl-piperidine compounds and method of use thereof
PH22427A (en) Eburnamenine derivatives and method of use thereof
GB2204313B (en) Novel bisbenzotrifluoride derivatives and method of preparing same
AR244943A1 (es) Composiciones insecticidas de o-piridilfosfato como agente activo.
EP0371136A4 (en) Postcard and method of preparing same
EP0377040A4 (en) Postcard and method of preparing same